Published in Br J Cancer on June 19, 2007
Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Mol Cancer Res (2008) 1.80
Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression. Clin Cancer Res (2008) 1.52
Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors. Cancer Res (2008) 1.38
SOCS, inflammation, and cancer. JAKSTAT (2013) 1.13
Understanding signaling cascades in melanoma. Photochem Photobiol (2007) 1.10
Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells. BMC Cancer (2010) 0.88
Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel. Oncotarget (2015) 0.88
Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients. J Cancer Res Clin Oncol (2014) 0.83
Autoimmunity as a double agent in tumor killing and cancer promotion. Front Immunol (2014) 0.83
Role of SOCS-1 Gene on Melanoma Cell Growth and Tumor Development. Transl Oncol (2011) 0.83
Tetraspanin CD37 protects against the development of B cell lymphoma. J Clin Invest (2016) 0.81
Short peptide type I interferon mimetics: therapeutics for experimental allergic encephalomyelitis, melanoma, and viral infections. J Interferon Cytokine Res (2014) 0.81
Tumour-promoting role of SOCS1 in colorectal cancer cells. Sci Rep (2015) 0.78
Dysregulation of SOCS-Mediated Negative Feedback of Cytokine Signaling in Carcinogenesis and Its Significance in Cancer Treatment. Front Immunol (2017) 0.75
IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient Small Cell Lung Cancer cells. J Exp Clin Cancer Res (2017) 0.75
Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell (1996) 10.44
SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell (1999) 4.29
SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet (2001) 3.76
Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature (1993) 3.73
STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol (2003) 3.04
Interferon alfa therapy for malignant melanoma: a systematic review of randomized controlled trials. J Clin Oncol (2002) 2.57
Cloning and characterization of novel CIS family genes. Biochem Biophys Res Commun (1997) 2.51
SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci U S A (2003) 2.12
Stats: multifaceted regulators of transcription. J Interferon Cytokine Res (2005) 2.02
Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma. J Biol Chem (1997) 1.76
Negative regulators of cytokine signal transduction. Cell Mol Life Sci (1999) 1.71
Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO J (2001) 1.59
Regulation of cytokine signaling by SOCS family molecules. Trends Immunol (2003) 1.58
SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene (2005) 1.55
Differential hypermethylation of SOCS genes in ovarian and breast carcinomas. Oncogene (2004) 1.51
Analysis of the tissue-specific promoter of the MUC1 gene. J Biol Chem (1993) 1.25
Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis. Oncogene (2006) 1.20
Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals. Oncogene (2006) 1.16
IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis. J Immunol (2002) 1.15
Constitutive expression of SOCS3 confers resistance to IFN-alpha in chronic myelogenous leukemia cells. Blood (2002) 1.13
Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma. J Invest Dermatol (2004) 1.11
Defective Jak-STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon-alpha. Int J Cancer (2000) 1.10
Stat1-independent induction of SOCS-3 by interferon-gamma is mediated by sustained activation of Stat3 in mouse embryonic fibroblasts. Biochem Biophys Res Commun (2005) 1.08
SOCS-1 and SOCS-3 inhibit IL-4 and IL-13 induced activation of Eotaxin-3/CCL26 gene expression in HEK293 cells. Mol Immunol (2005) 1.07
Epigenetic switch from posttranscriptional to transcriptional silencing is correlated with promoter hypermethylation. Plant Physiol (2003) 1.03
Hypermethylation-associated inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human pancreatic cancers. Jpn J Clin Oncol (2004) 0.99
Loss of STAT1 expression confers resistance to IFN-gamma-induced apoptosis in ME180 cells. FEBS Lett (1999) 0.99
STAT5 contributes to interferon resistance of melanoma cells. Curr Biol (2005) 0.96
Expression of STAT1 and STAT2 in malignant melanoma does not correlate with response to interferon-alpha adjuvant therapy. Cancer Immunol Immunother (2005) 0.96
Interferon-gamma-mediated growth regulation of melanoma cells: involvement of STAT1-dependent and STAT1-independent signals. J Invest Dermatol (2004) 0.95
Cellular responses to interferons and other cytokines: the JAK-STAT paradigm. N Engl J Med (1998) 0.93
The JAK/STAT pathway is not sufficient to sustain the antiproliferative response in an interferon-resistant human melanoma cell line. Melanoma Res (2003) 0.92
Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions. Cancer Res (1993) 0.85
Interferon-gamma, but not interferon-alpha, induces SOCS 3 expression in human melanoma cell lines. Melanoma Res (2005) 0.84
Clonal selection versus genetic instability as the driving force in neoplastic transformation. Cancer Res (2000) 0.81
Malignant melanoma associates with deficient IFN-induced STAT 1 phosphorylation. Int J Mol Med (2003) 0.80
Interferon inducibility of STAT 1 activation and its prognostic significance in melanoma patients. Folia Biol (Praha) (2003) 0.77
Regulation of bacterial cell division: temperature-sensitive mutants of Escherichia coli that are defective in septum formation. J Bacteriol (1975) 3.94
Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med (1999) 2.33
The ups and downs of genome size evolution in polyploid species of Nicotiana (Solanaceae). Ann Bot (2008) 1.57
Uptake and activity of rifapentine in human peritoneal macrophages and polymorphonuclear leukocytes. Eur J Clin Microbiol (1987) 1.55
Are advanced malignant melanoma cells hybrids between melanocytes and macrophages? Melanoma Res (1992) 1.54
Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein. Oncogene (1995) 1.51
Operations on the thoracic aorta and hypothermic circulatory arrest: is aprotinin safe? J Thorac Cardiovasc Surg (1998) 1.38
Gene conversion of ribosomal DNA in Nicotiana tabacum is associated with undermethylated, decondensed and probably active gene units. Chromosoma (2000) 1.36
Preferential elimination of repeated DNA sequences from the paternal, Nicotiana tomentosiformis genome donor of a synthetic, allotetraploid tobacco. New Phytol (2005) 1.35
The chemokine receptor Cxcr3 is not essential for acute cardiac allograft rejection in mice and rats. Am J Transplant (2008) 1.31
Listeria monocytogenes modulates macrophage cytokine responses through STAT serine phosphorylation and the induction of suppressor of cytokine signaling 3. J Immunol (2001) 1.22
Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur J Immunol (1998) 1.20
Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis? Urology (1999) 1.18
JAK/STAT signaling pathways and cancer. Janus kinases/signal transducers and activators of transcription. Neoplasma (2002) 1.18
Disappearance of uraemic pruritus after lowering dialysate magnesium concentration. Br Med J (1979) 1.17
Mobilization of retrotransposons in synthetic allotetraploid tobacco. New Phytol (2010) 1.10
Cytokine release and dynamics of leukocyte populations after CD3/TCR monoclonal antibody treatment. J Clin Immunol (1992) 1.09
Up-regulation of Fas (CD95) in human p53wild-type cancer cells treated with ionizing radiation. Int J Cancer (1997) 1.08
Dynamic changes in the distribution of a satellite homologous to intergenic 26-18S rDNA spacer in the evolution of Nicotiana. Genetics (2004) 1.04
Induction of neonatal TH1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells? Vaccine (1998) 1.02
Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early life. Eur J Immunol (2001) 0.99
Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients. Hum Reprod (2008) 0.99
Determinants of infant responses to vaccines in presence of maternal antibodies. Vaccine (1998) 0.99
Lysis of Saccharomyces cerevisiae with 2-deoxy-2-fluoro-D-glucose, an inhibitor of the cell wall glucan synthesis. J Bacteriol (1973) 0.99
Natural killer cell activity and antibody-dependent cellular cytotoxicity in patients under various immunosuppressive regimens. Clin Immunol Immunopathol (1987) 0.95
Renin-angiotensin-aldosterone system in cyclosporin A-treated renal allograft recipients. Nephron (1985) 0.95
Renin-angiotensin-aldosterone system and vasopressin in cyclosporine-treated renal allograft recipients. Clin Nephrol (1987) 0.95
Evaluation of arteriovenous fistulas and pseudoaneurysms in renal allografts following percutaneous needle biopsy. Color-coded Doppler sonography versus duplex Doppler sonography. J Ultrasound Med (1990) 0.94
High dose-rate microselectron molds in the treatment of skin tumors. Int J Radiat Oncol Biol Phys (1995) 0.93
The histopathologic identification of CMV infected cells in biopsies of human renal allografts. An evaluation of 100 transplant biopsies by in situ hybridization. Pathol Res Pract (1986) 0.92
Chronic gastrointestinal symptoms in hemodialysis patients. Wien Klin Wochenschr (1998) 0.92
Making a functional diploid: from polysomic to disomic inheritance. New Phytol (2009) 0.92
Distribution of individual components of basement membrane in human colon polyps and adenocarcinomas as revealed by monoclonal antibodies. Int J Cancer (1992) 0.91
Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int (1987) 0.90
Detection of keratin subtypes in routinely processed cervical tissue: implications for tumour classification and the study of cervix cancer aetiology. Virchows Arch (1994) 0.90
Immunochemical analysis of the p53 oncoprotein in matched primary and metastatic human tumours. Eur J Cancer (1993) 0.90
Anemia and carnitine supplementation in hemodialyzed patients. Kidney Int Suppl (1999) 0.89
Peripheral insulin resistance in primary hyperparathyroidism. Metabolism (1983) 0.88
Effects of 8 weeks of vibration training at different frequencies (1 or 15 Hz) in senior sportsmen on torque and force development and of 1 year of training on muscle fibers. Neurol Res (2010) 0.88
Molecular cytogenetics and tandem repeat sequence evolution in the allopolyploid Nicotiana rustica compared with diploid progenitors N. paniculata and N. undulata. Cytogenet Genome Res (2005) 0.88
Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice. Eur J Immunol (1999) 0.87
Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis. Clin Exp Immunol (2001) 0.87
Successful parathyroidectomy in primary hyperparathyroidism: a clinical follow-up study of 212 consecutive patients. Surgery (1987) 0.86
[Serum cobalt and serum chromium level in 2 patients with chronic renal failure after total hip prosthesis implantation with metal-metal gliding contact]. Z Orthop Ihre Grenzgeb (2001) 0.86
Hepatitis C antibody in renal transplant patients. Transplant Proc (1992) 0.85
Epidermal growth factor receptor (EGFR) expression and mutations in the EGFR signaling pathway in correlation with anti-EGFR therapy in head and neck squamous cell carcinomas. Neoplasma (2012) 0.85
Rapidly progressive glomerulonephritis and carcinoma of the hypopharynx. Am J Kidney Dis (2001) 0.84
Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro. J Immunol (1994) 0.84
p53 derived from human tumour cell lines and containing distinct point mutations can be activated to bind its consensus target sequence. Oncogene (1995) 0.84
Novel monoclonal antibodies defining epitope of human cytokeratin 18 molecule. Hybridoma (1988) 0.84
Prediction of long-term clinical outcome in patients with lumbar spinal stenosis. Eur Spine J (2012) 0.84
Absence of p53 autoantibodies in a significant proportion of breast cancer patients. Br J Cancer (1995) 0.83
Relationship of interferon-gamma and neopterin levels during stimulation with alloantigens in vivo and in vitro. Transplantation (1986) 0.83
A comparison of organ cultured fetal pancreas allo-, iso-, and xenografts (pig) in non-immunosuppressed non-obese diabetic mice. Am J Pathol (1995) 0.83
A permissive effect of cyclosporin on the development of isohaemagglutinins of graft origin in ABO-mismatched organ transplantation. Nephrol Dial Transplant (1988) 0.83
Phrenic nerve block as a complication of local anesthetic. Infiltration for internal jugular vein catheterization. Anesthesiology (1989) 0.83
Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients. Transplantation (2000) 0.82
The pathophysiologic role of endothelin in acute vascular rejection after renal transplantation. Transplantation (1991) 0.82
Impact of high-dose oral acyclovir prophylaxis on cytomegalovirus (CMV) disease in CMV high-risk renal transplant recipients. J Am Soc Nephrol (1996) 0.82
Secondary hyperparathyroidism and acute tubular necrosis following renal transplantation. Nephrol Dial Transplant (1993) 0.82
Glucose metabolism and insulin sensitivity in patients on chronic hemodialysis. Metabolism (1985) 0.82
Ribosomal DNA evolution and gene conversion in Nicotiana rustica. Heredity (Edinb) (2003) 0.82
Pathophysiology of dialysis related hypoxaemia. Proc Eur Dial Transplant Assoc (1980) 0.82
Primary hyperparathyroidism is associated with decreased insulin receptor binding and glucose intolerance. Calcif Tissue Int (1984) 0.81
Progression of chronic renal failure. Lancet (1988) 0.81
The effects of lisinopril on renal function in proteinuric renal transplant recipients. Transplantation (1993) 0.81
Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients. Neoplasma (2011) 0.80
[Sonographically demonstrable changes following percutaneous kidney biopsy]. Ultraschall Med (1986) 0.80
Malignant melanoma associates with deficient IFN-induced STAT 1 phosphorylation. Int J Mol Med (2003) 0.80
Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver. Hepatogastroenterology (1999) 0.80
Postprandial intradialytic dysglycaemia and diabetes in maintenance haemodialysis patients. Eur J Clin Invest (2008) 0.80
Aluminum removal by hemodialysis. Kidney Int (1981) 0.80
[Calcium and phosphorus metabolism in patients on chronic intermittent haemodialysis with different calcium concentrations in the dialysate (author's transl)]. Wien Klin Wochenschr (1979) 0.79
[Hyperparathyroidism in chronic renal insufficiency new clinical and surgical aspects (author's transl)]. Wien Klin Wochenschr (1981) 0.79
Induction of alloantigen-specific hyporesponsiveness in vitro by the short-chain fatty acid N-butyrate. Transplantation (1995) 0.79
Monofunctional and Interstrand DNA Adducts of Platinum(II) Complexes. Met Based Drugs (1994) 0.79
Calcitonin in pregnancy. Lancet (1980) 0.79
Pharmacokinetic cyclosporine A profiles under long-term Neoral treatment in renal transplant recipients: does fat intake still matter? Transplant Proc (1997) 0.79
Determination of parathyroid function after autotransplantation. Surgery (1981) 0.78
Long-term outcome with interstitial brachytherapy boost in the treatment of women with early-stage breast cancer. Neoplasma (2007) 0.78
[Phosphorus and calcium metabolism of premature infants fed human milk and formulated milk]. Padiatr Padol (1982) 0.78
Induction of alloantigen-specific hyporesponsiveness in vitro by n-butyrate: antagonistic effect of cyclosporin A. Transpl Int (1996) 0.78
Parathyroid hormone does not inhibit platelet aggregation. Lancet (1984) 0.78
Can treatment with the monoclonal antibody BMA031 induce cytokine release? Transplant Proc (1992) 0.78
High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission. Neoplasma (2008) 0.78
Long-term outcome in renal patients beyond five years after kidney transplantation. Transplant Proc (1989) 0.78
The influence of 5-azacytidine on the condensation of the short arm of rye chromosome 1R in Triticum aestivum L. root tip meristematic nuclei. Chromosoma (1997) 0.78
Defective IFNα/γ-induced STAT3 protein activation in human malignant melanoma cells. Mol Med Rep (2011) 0.77
Ofloxacin clearance during hemodialysis: a comparison of polysulfone and cellulose acetate hemodialyzers. Am J Kidney Dis (1998) 0.77
Reduced inducibility of SOCS3 by interferon gamma associates with higher resistance of human breast cancer lines as compared to normal mammary epithelial cells. Neoplasma (2009) 0.77
Strain-specific difference that affects the inhibition of division of Escherichia coli filaments by chloramphenicol. J Bacteriol (1975) 0.77
Effect of mycophenolate mofetil with and without anti-CD4 (GK1.5) on fetal islet iso-, allo-, and xenografts in NOD/Lt female mice. Transplant Proc (1997) 0.77
Multiple-dose pharmacokinetics of a long half-life drug: contributions of mathematical modeling. Eur J Drug Metab Pharmacokinet (1997) 0.77